Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations.
Agata S, Viel A, Della Puppa L, Cortesi L, Fersini G, Callegaro M, Dalla Palma M, Dolcetti R, Federico M, Venuta S, Miolo G, D'Andrea E, Montagna M. Agata S, et al. Among authors: miolo g. Genes Chromosomes Cancer. 2006 Sep;45(9):791-7. doi: 10.1002/gcc.20342. Genes Chromosomes Cancer. 2006. PMID: 16715518
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Muraro E, Martorelli D, Turchet E, Miolo G, Scalone S, Comaro E, Talamini R, Mastorci K, Lombardi D, Perin T, Carbone A, Veronesi A, Crivellari D, Dolcetti R. Muraro E, et al. Among authors: miolo g. Breast Cancer Res. 2011;13(6):R117. doi: 10.1186/bcr3060. Breast Cancer Res. 2011. PMID: 22112244 Free PMC article.
Target therapy in elderly breast cancer patients.
Carli P, Turchet E, Quitadamo D, Spada A, Miolo G, Lamaj E, Spazzapan S, Di Lauro V, Dolcetti R, Veronesi A, Crivellari D. Carli P, et al. Among authors: miolo g. Crit Rev Oncol Hematol. 2012 Sep;83(3):422-31. doi: 10.1016/j.critrevonc.2011.12.004. Epub 2012 Jan 17. Crit Rev Oncol Hematol. 2012. PMID: 22257652 Review.
Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST.
Gasparotto D, Miolo G, Torrisi E, Canzonieri V, Bertola G, Libra M, Marzotto A, Maestro R, Buonadonna A. Gasparotto D, et al. Among authors: miolo g. Int J Colorectal Dis. 2014 May;29(5):639-40. doi: 10.1007/s00384-014-1838-6. Epub 2014 Feb 15. Int J Colorectal Dis. 2014. PMID: 24525699 No abstract available.
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.
Miolo G, Muraro E, Martorelli D, Lombardi D, Scalone S, Spazzapan S, Massarut S, Perin T, Viel E, Comaro E, Talamini R, Bidoli E, Turchet E, Crivellari D, Dolcetti R. Miolo G, et al. BMC Cancer. 2014 Dec 15;14:954. doi: 10.1186/1471-2407-14-954. BMC Cancer. 2014. PMID: 25512030 Free PMC article. Clinical Trial.
Morphologic shift associated with aberrant cytokeratin expression in a GIST patient after tyrosine kinase inhibitors therapy. A case report with a brief review of the literature.
Canzonieri V, Gasparotto D, Alessandrini L, Miolo G, Torrisi E, Perin T, De Paoli P, Maestro R, Buonadonna A. Canzonieri V, et al. Among authors: miolo g. Pathol Res Pract. 2016 Jan;212(1):63-7. doi: 10.1016/j.prp.2015.11.004. Epub 2015 Nov 10. Pathol Res Pract. 2016. PMID: 26616113 Free article. Review.
147 results